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Vertebrates develop organs and appendages in a
proportionally coordinated manner, and animals
that regenerate them do so to the same dimensions
as the original structures. Coordinated proportional
growth involves controlled regulation between
allometric and isometric growth programs, but it is
unclear what executes this control. We show that
calcineurin inhibition results in continued allometric
outgrowth of regenerating fins beyond their original
dimensions. Calcineurin inhibition also maintains
allometric growth of juvenile fins and induces it in
adult fins. Furthermore, calcineurin activity is low
when the regeneration rate is highest, and its activity
increases as the rate decreases. Growth measure-
ments and morphometric analysis of proximodistal
asymmetry indicate that calcineurin inhibition shifts
fin regeneration from a distal growth program to a
proximal program. This shift is associated with the
promotion of retinoic acid signaling. Thus, we iden-
tified a calcineurin-mediated mechanism that oper-
ates as a molecular switch between position-associ-
ated isometric and allometric growth programs.
INTRODUCTION
All animal species develop organs and limbs to specific propor-
tions relative to body size, and animals that regenerate have the
ability to redevelop these structures to their original dimensions.
The animal kingdom exhibits numerous examples of variation in
the specific dimensions of organ and appendage sizes. This
variability involves coordinated changes in tissue growth rates,
which can either be proportionate (isometric) or disproportionate
(allometric) to the rest of the body.
Like organs and appendages of tetrapods, zebrafish fins grow
in specific proportions to the size of the body, and these propor-
tions are regained after regeneration (Goldsmith et al., 2003;
Iovine and Johnson, 2000). The fin has awell-organized architec-
ture composed of nerves, vasculature, mesenchyme, skin,
pigment, and connective tissue supported by a bone frame (Be-Develocerra et al., 1983). These tissues initially grow allometrically in
relation to the body size during early juvenile development
(Goldsmith et al., 2006), but their growth subsequently becomes
isometric once the adult fin shape is reached (Goldsmith et al.,
2003; Iovine and Johnson, 2000). However, partial loss of the
fin results in the regeneration of the missing tissue to the original
adult size by inducing allometric growth, which progresses to an
isometric growth rate as the regenerating tissues approach their
original dimensions. The rate of the allometric regenerative
outgrowth correlates with proximodistal location of the injury
(Lee et al., 2005).
Developmental and regenerative growth is regulated by local
factors such as released ligands, adhesion molecules, and
connexins as well as systemic circulating hormones (Hoptak-
Solga et al., 2008; Lee et al., 2005; Schwartz and Assoian,
2001; Yakar et al., 2002). Although several molecular factors
and mechanisms have been identified that regulate cell prolifer-
ation and tissue growth, it is still unclear what mechanisms are
involved in coordinating these phenomena to generate com-
pound structures to precise proportional dimensions and in rees-
tablishing appropriate size during regeneration.
We show that treatment with two calcineurin inhibitors, FK506
and cyclosporin A (CsA), override the intrinsic dimensional
growth control of both regenerating and uninjured fins, and
that this is associated with maintenance of a proximal growth
program, a disproportionate increase in proximal structures, an
enlargement of the blastema to a size typical of proximal re-
generation, and the establishment of a transcriptional profile
consistent with the promotion of retinoic acid signaling, a signal
transduction pathway known to proximalize appendages. In
summary, our findings identify a calcineurin-mediated mecha-
nism that acts as a switch between isometric and allometric
coordinated growth of developing and regenerating zebrafish
fin appendages.RESULTS
Treatment with Tacrolimus Causes Excessive
Regenerative Fin Outgrowth
The immune response after injury can have either beneficial or
deleterious effects on regeneration (Eming et al., 2009). We
therefore tested how immunosuppression with Tacrolimus
(FK506) influenced regeneration of the zebrafish caudal fin.pmental Cell 28, 573–587, March 10, 2014 ª2014 Elsevier Inc. 573
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Calcineurin Inhibition Enhances Fin RegenerationThe adult caudal fin is a bilobed structure that maintains a
specific proportion to the body (Iovine and Johnson, 2000)
(Figure 1A). Partial amputation of caudal fins (Figure 1B) results
in a regeneration response that completely restores them to their
original size (original size: 6.8 ± 0.3 mm; regenerated size: 6.9 ±
0.2 mm; two-tailed, paired t test p = 0.59) by 28 days postampu-
tation (dpa) (Figure 1C), whereas, compared to the original
dimensions (Figure 1D), FK506 treatment after partial amputa-
tion of the fins (Figure 1E) causes excessive regenerative
outgrowth (Figure 1F). This difference was even more pro-
nounced at 70 dpa (original size 7.3 ± 0.4 mm; regenerated
size 12.6 ± 0.9 mm; two-tailed, paired t test p% 0.0005), demon-
strating that FK506 treatment enhances regenerative outgrowth
to create fins that are disproportionate to the body size.
To determine whether the excessive fin growth is caused by
a temporary increase in the rate of growth or by continual growth
over an extended period of time, we measured fin growth of
treated fish over the course of regeneration (Figure 1G). Because
body length measurements (tip of the jaw to the base of
the caudal fin) showed no difference in growth between
FK506-treated and DMSO-treated control animals (Figure 1G),
we used body length to normalize our fin-length measurements.
Regenerating fins of DMSO-treated control animals grew at
a high rate for approximately the first 3 weeks, after which
the rate of regenerative growth decreased and finally reached
a near plateau at the original fin size (Figure 1H, arrow). The
growth rate of FK506-treated fins started to differ from the
control rate around 7 dpa (Figure 1H, arrowhead) and displayed
an increased growth rate beyond 4 weeks (Figure 1H, arrow).
Measurements from the base of the fins to the amputation
planes showed that the location of the amputation plane did
not shift distally, indicating that the enhanced growth induced
by FK506 treatment occurred in the distal regenerate (Figures
S1A–S1C available online). The enhanced regenerative growth
also occurred in other fins after amputation (Figures S1D–S1H).
Histological and tissue morphometry analyses revealed no
differences between regenerating DMSO-control fins andFigure 1. Treatment with FK506 Enhances Regenerative Outgrowth of
(A and D) Caudal fins of adult fish before treatments.
(B and E) Amputated adult fins pretreatment.
(C) DMSO-treated regenerated fin 28 days postamputation (dpa).
(F) FK506-treated regenerated fin 28 dpa.
(G) Graphed measurements of DMSO-, FK506-treated fish from the base of th
treatment group before and after 70 days of treatments of adult fish with regene
(H) Graph of fin growth rates during DMSO and FK506 treatments normalized to b
size and return to isometric growth. Arrowhead indicates the time point where d
(I) Whole-mount in situ hybridization experiments (ISH) for fkbp1Aa expression o
(I0) Magnification of box in (I).
(J) Cross-section through regenerating fin 3 dpa shows strong expression of fkb
(K) Expression of fkbp10 in a 3 dpa fin.
(K0) Magnification of box in (K).
(L) Cross-section through regenerating fin 3 dpa shows expression of fkbp10 in
(M) Expression of fkbp14 in 3 dpa fin.
(M0) Magnification of box in (M).
(N) Cross-section through regenerating fin 3 dpa shows expression of fkbp14 in
(O) qRT-PCR results comparing difference in fold expression of regeneration-a
baseline expression in DMSO-treated fish, and the black bars show average inc
In (G) and (H), data are represented as mean ± SD of three experiments each wit
more fins from three or more experiments. In (O), each point represents qRT-PCR
200 mm (I, I0, K, K0, M, and M0), and 20 mm (J, L, and N). See also Figures S1 and
DeveloFK506-treated fins (Figures S2A–S2H). Nor did we observe any
instances of tumorous growth; rather, all tissues grew in a coor-
dinated manner (Figures S2A–S2D).
FK506 acts through binding to FK506-binding proteins
(FKBPs) (Harding et al., 1989; Siekierka et al., 1989). As shown
by in situ hybridization experiments, the principle target of
FK506 fkbp1Aa (fkbp12a) (Figures 1I and 1J) (Harding et al.,
1989) as well as alternative candidate interaction partners
fkbp10 (Figures 1K and 1L) and fkbp14 (Figures 1M and 1N)
(Coss et al., 1995; Rulten et al., 2006) were expressed in the
blastemas (Figures 1J, 1L, and 1N) of regenerating fins, suggest-
ing that FK506 is regulating regenerative fin growth by acting in
the blastema cells.
To determine whether the extended outgrowth of the FK506-
treated regenerating fins is associated with the continued
expression of genes active during fin regeneration, wemeasured
the expression of candidate genes by quantitative RT-PCR (qRT-
PCR) at 28 dpa. In comparison to the transcriptional activity in
the DMSO controls, the tested genes were all upregulated in
the FK506-treated fish (Figure 1O), indicating that the continued
outgrowth is due to the maintenance of the proregenerative
transcriptional program.
FK506 Enhances the Growth of Uninjured Adult Fins
The adult zebrafish body and its appendages grow isometrically
(Goldsmith et al., 2003; Iovine and Johnson, 2000). The ability of
FK506 to maintain allometric growth and override isometric
growth control of the regenerating fins suggests that it may be
able to override the isometric growth control of uninjured fins.
To test this, we treated uninjured fish either with DMSO or
FK506 for 5 days. Compared to controls (Figures 2A and 2B),
fins showed an increase in length after FK506 treatment (Figures
2C and 2D). Although DMSO-treated control fins did incorporate
bromodeoxyuridine (BrdU) in at the distal tip of the fin (Figures
S2I and S2J), FK506-treated fins showed both more BrdU in-
corporation at a higher density at the distal fin tip and over a
broader distance at the distal end of the fin, indicating that theAdult Caudal Fin
e fin to the tip of the mouth shows no significant differences between each
rating caudal fins.
ody length. Arrow indicates the time point when control fins reach their original
ifferences in growth rate become apparent.
f 3 dpa regenerating fin.
p1Aa in the blastema and weak expression in epidermis.
the blastema.
the blastema.
ssociated genes for FK506- over DMSO-treated fins. The dashed line shows
reased fold expression of each gene in FK506- over DMSO-treated fins.
h five or more animals. In (I)–(N), each panel represents in situ results of two or
experiments of a cDNA pool of eight harvested fins. Scale bars, 1 mm (A–F),
S2.
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Figure 2. FK506 Treatment of Uninjured Adult Fish Induces Allometric Growth of the Fin
(A and B) Adult caudal fin (A) before DMSO treatment at 0 days posttreatment (dpt) and (B) after DMSO treatment for 14 days.
(C and D) Fin (C) before FK506 treatment and (D) after treatment with FK506 14 dpt.
(E) Graph of DMSO- and FK506-treated fin measurements at 14 dpt. ***p < 0.005.
(legend continued on next page)
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Figure 3. Treatment with FK506 Enhances
Outgrowth of the Developing Juvenile Fin
(A) Caudal fin of a juvenile fish at 30 days post-
fertilization (dpf).
(B) Fin of the same 65 dpf fish in (A) after DMSO
treatment for 35 days.
(C) Adult fin of fish 118 dpf after DMSO treatment
for 88 days.
(D) Caudal fin of a juvenile fish 30 dpf before FK506
treatment.
(E) Fin of same fish 65 dpf after FK506 treatment
for 35 days.
(F) Caudal fin of fish 118 dpf after FK506 treatment
for 88 days.
(G) Body length measurements of treated juvenile
fish during growth. Regression lines for slopes are
0.0025 fin/body ratio per day for FK506 treated and
0.00018 fin/body ratio per day for DMSO control.
(H) Graph shows growth as fin-to-body ratio of
treatment groups.
Scale bars, 500 mm (A–F). In (G) and (H), data are
represented as mean ± SD from two experiments
each containing six or more animals.
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liferation at the distal tip of the fin (Figures S2K–S2M). Measure-
ments of both groups showed an average 5-fold growth
enhancement of fins treated with FK506 after 14 days (Figure 2E)
and, compared to controls (Figures 2F and 2G), continued FK506
treatment produced clearly enlarged caudal fins (Figures 2H and
2I), despite no effect on the trunk (Figure 2J). These results
demonstrate that FK506 treatment regulates a mechanism that
acts as a switch between isometric and allometric growth control
of fish appendages.
Theonset of allometric growth in unamputatedfinswasaccom-
paniedby the upregulation of lef1 (Figures 2K and 2L), raldh2 (Fig-
ures 2M and 2N), and shh (Figures 2O and 2P) at 14 days post-
treatment (dpt). Furthermore, fa93e10, a gene associated with
fin outgrowth (Goldsmith et al., 2003), was absent in DMSO-
treated fins (Figure 2Q) but activated in FK506-treated fins (Fig-(F and H) Caudal fins before treatment.
(G) Same adult fin in (F) after 42 dpt with DMSO.
(I) Same adult fin in (H) after 42 dpt with FK506.
(J) Graph shows no significant differences in body lengths before and after 42 days of treatment either with
(K) ISH for lef1 in DMSO-treated fin at 5 dpt.
(L) lef1 ISH in FK506-treated fin at 5 dpt.
(M) ISH for raldh2 expression in DMSO-treated fin at 5 dpt.
(N) ISH for raldh2 expression in FK506-treated fin 5 dpt.
(O) ISH for shh expression in DMSO-treated fin at 5 dpt.
(P) ISH for shh expression in FK506-treated fin at 5 dpt.
(Q) ISH for fa93e10 expression in DMSO-treated fin 5 dpt.
(R) ISH for fa93e10 expression in FK506-treated fin 5 dpt.
(S) qRT-PCR results showing differences in fold gene expression of FK506-treated over DMSO-treated fins
Asterisks in (A)–(D) demarcate the same segment before and after treatments, and lines indicate length of m
qRT-PCR result from a cDNA pool of eight fins. In (K)–(R), each panel represents in situ results of two or mor
0.1 mm (A–D and F–I) and 200 mm (K–R).
Developmental Cell 28, 573–58ure 2R). qRT-PCR analyses for additional
proregeneration genes showed that the
transcription of several genes from
different principal signal transduction
pathways (Wnt, Fgf, Bmp, retinoic acid,and Notch) were upregulated by FK506 treatment of unampu-
tated fins at 14 dpt (Figure 2S). However, not all genes induced
during fin regeneration (Akimenko et al., 1995; Monnot et al.,
1999), while present, were upregulated (Figure 2S), suggesting
that increased expression of these genes is not required for
FK506-mediated growth. Together, these data demonstrate that
FK506 treatmentof uninjuredfins inducesallometric finoutgrowth
and activates genes associated with the regenerative program.
FK506 Enhances Juvenile Outgrowth of the Fin
The early development of the juvenile fin also involves allometric
growth to obtain the adult structure (Park et al., 2002). We there-
fore assessed whether treating fish with FK506 during juvenile
development affects the rate of fin growth. Thirty-day-old juve-
nile fish already have developed the adult fin architecture (Fig-
ure 3A) and grow isometrically 35 days dpt with DMSODMSO or FK506.
at 14 dpt.
easurement. In (E) and (S), each point represents
e fins from three or more experiments. Scale bars,
7, March 10, 2014 ª2014 Elsevier Inc. 577
Figure 4. FK506-Enhanced Regenerative
Outgrowth Is Not Due to Immunosuppres-
sion
(A, D, and G) Caudal fins before treatments and
amputation.
(B, E, and H) Corresponding amputated adult fins
pretreatment.
(C) DMSO-treated regenerated fin at 35 dpa.
(F) Rapamycin-treated regenerated fin 35 dpa.
(I) FK506-treated regenerated fin at 35 dpa.
(J) Graph of fin-to-body length ratios during the
course of regeneration. Dashed line indicates
original fin-to-body-length ratio.
(K) Fin-to-body length ratio measurements during
the regeneration time course of DMSO- and
Celastrol-treated fish.
(L) Fin-to-body-length measurements during re-
generation time course from fish injected with
DMSO, FK506, rapamycin, or Celastrol.
In (C), (F), and (I), black arrowheads mark the
amputation planes. Black lines show the extent of
regenerative outgrowth and red lines highlight the
length of the entire caudal fin. Scale bars, 1 mm
(A–I). In (J)–(L), data are represented as mean ± SD
from two or more experiments containing six or
more animals. See also Figure S3.
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Calcineurin Inhibition Enhances Fin Regeneration(Figure 3B) and 88 dpt (Figure 3C). Although the fins of juvenile
fish showed the same size dimensions at the onset of FK506
treatment (Figure 3D), they showed a significant increase in
size after 35 dpt in FK506 (Figure 3E), which became even
more pronounced after 88 dpt (Figure 3F). Importantly, the effect
of FK506 was restricted to the fins, because growth of the body
length from the jaw to the base of the caudal fin was not signifi-
cantly affected (Figure 3G, one-tailed t test p = 0.13). Although
caudal fins of DMSO-treated controls grew isometrically with
the body, the fins of FK506-treated juvenile fish exhibited near
linear allometric growth (Figure 3H). Together, these data further578 Developmental Cell 28, 573–587, March 10, 2014 ª2014 Elsevier Inc.demonstrate that FK506 affects amecha-
nism that controls an endogenous switch
between isometric and allometric growth.
Overgrowth Is Not Due to
Immunosuppression
FK506 is an immunosuppressant, and
published results show that immuno-
suppression can promote tumorous
growth in mammalian keratinocytes as
well as regenerative outgrowth during
the refractory period of the Xenopus
tadpole (Dunn et al., 2004; Fukazawa
et al., 2009). To determine whether
general suppression of the immune
system is the mechanism for the FK506-
mediated outgrowth phenotype, we
treated fish with other immunosuppres-
sants during regenerative outgrowth of
the adult fin.
Rapamycin also binds to FKBPs
(FK506 binding proteins), and the rapa-mycin-FKBP complex blocks the immune response by sup-
pressing the activity of the target of rapamycin (TOR) kinase
(Bierer et al., 1990; Weiwad et al., 2006). Compared to DMSO-
treated controls (Figures 4A–4C), rapamycin did not cause
enhanced outgrowth or alter body length (Figure S3A); rather,
the treated fish initially displayed fins slightly smaller than original
size (6.8 ± 0.2 mm pretreatment versus 6.0 ± 0.5 mm posttreat-
ment p% 0.02, one-tailed, paired t test) after 28 days, but even-
tually grew to their original size (Figures 4D–4F), whereas FK506
treatment enhanced regenerative outgrowth (Figures 4G–4I).
Quantitative assessment of the fin-to-body ratios of regenerating
Developmental Cell
Calcineurin Inhibition Enhances Fin Regenerationfins from DMSO- and rapamycin-treated fish showed that
rapamycin-treated regenerating fins grew at a rate lower than
controls and only reached their original size after 6 weeks
(Figure 4J).
We also treated fish with Celastrol, an immunosuppressant
that inhibits the NF-kB-mediated immune response (Lee et al.,
2006). Constantly, Celastrol treatment also failed to produce
an overgrowth phenotype (Figure 4K) or a change in body size
(Figure S3B). To circumvent possible problems of bioavailability,
we injected the drugs intraperitoneally and observed that rapa-
mycin or Celastrol did not enhance regenerative outgrowth,
whereas FK506 did (Figure 4L). The lack of enhanced growth
by other immunosuppressants argues that FK506 enhances
growth by regulating a FK506-specific target.
Calcineurin Inhibition Enhances Regenerative
Outgrowth
The interaction between FK506 and FKBPs forms a FK506-
FKBP complex that binds to the protein phosphatase calcineurin
and inhibits its activity (Liu et al., 1991). Cyclosporin A (CsA) also
inhibits calcineurin but does so through a different drug-protein
interaction (Cyclophilins, CyP) than FK506 (Schreiber and Crab-
tree, 1992). To assess whether inhibiting calcineurin causes the
FK506-induced phenotype, we tested whether CsA also
enhanced the regenerative outgrowth. Compared to the controls
(Figure 5A–5C), fins from fish treated with FK506 (Figures 5D–5F)
or CsA (Figures 5G–5I) displayed enhanced regenerative
outgrowth by 38 dpa. This was more pronounced by 70 dpa
(original size 6.6 ± 0.07 mm; regenerated size 9.6 ± 0.9 mm;
one-tailed t test p% 0.01). Time course measurements showed
that CsA produced an enhanced growth profile similar to FK506
(Figure 5J), and did not increase body size (Figure S4). Thus, CsA
treatment also overrides the growth control that determines
appendage size, and, as expected, both drugs significantly
inhibited calcineurin activity (Figure 5K), arguing that their
common inhibitory effect on calcineurin produces the allometric
appendage growth. This was also supported by the lack of
enhanced growth after treatment with a synthetic chemical de-
rivative of FK506, Synthetic Ligand of FKBP (SLF), which also
binds to FKBPs and inhibits the peptidyl prolyl cis-trans activity
of the immunophilins but does not affect calcineurin activity
(Holt et al., 1993) (Figures S5A–S5D).
Endogenous Calcineurin Activity Inhibited during
Allometric Growth of Regeneration
The specificity of FK506-FKBP and CsA-CyP complexes for
calcineurin and the resulting phenotype argue that calcineurin
is present in the regenerating fin. From in situ hybridization ex-
periments, we observed an expression pattern for the catalytic
subunit of calcineurin (ppp3cc) primarily in the blastema with
weaker expression in the overlying epidermis (Figures 5L and
5M), a pattern similar to the fkbp (Figures 1I, 1K, and 1M) immu-
nophilins that in combination with FK506 inhibit calcineurin enzy-
matic activity (Figure 5K).
The promotion of allometric regenerative growth by calci-
neurin inhibition leads to the prediction that calcineurin activity
is low when growth of the regenerating fin is allometric and
subsequently rises as the fin returns to isometric growth. We
therefore examined calcineurin phosphatase activity levels atDevelodifferent time points during regeneration. Once the blastema
has formed after 2 dpa, allometric growth is highest between 3
and 7 dpa (Figure 1H, blue curve). In comparison to isometrically
growing unamputated fins, measurements of calcineurin phos-
phatase activity in 3 dpa regenerates showed a significant
reduction in activity (Figure 5N). We also observed increased
activity at 10 dpa (Figure 5N) as the growth rate lowered (Fig-
ure 5J, blue curve) and returned to preamputation values once
the fin returned to isometric growth by 31 dpa (Figures 5J and
5N). This inverse relationship between calcineurin phosphatase
activity and growth rate strongly argues that calcineurin is
involved in regulating allometric growth.
Enhanced Regenerative Outgrowth Is a Consequence of
Change in Positional Information
Proximal fin structures regenerate at a higher rate than distal
structures (Lee et al., 2005), suggesting the maintenance of a
higher rate of growth by FK506 or CsA treatment is due to
altering the generation or interpretation of positional information
that determines the rate of growth. To test this hypothesis, we
amputated one lobe of the caudal fin at a proximal site and the
other at a distal site. In controls (Figure 6A), the more proximally
amputated ventral lobe regenerated at a higher rate than the
distally amputated dorsal lobe (Figure 6C) so that both lobes
reached the original fin length at the same time point (Figures
6A and 6E). In contrast, FK506 treatment caused both lobes to
grow at the higher rate characteristic of the proximal regenerate
of controls, which resulted in an asymmetric fin shape (Figures
6B and 6D). As a consequence, in control fins, the growth
profiles of the proximal and distal regenerating tissues eventually
converged (Figure 6E), whereas FK506-treated fins maintained
nonconvergent growth of the proximally and distally amputated
lobes (Figure 6F). We therefore hypothesized that the enhanced
growth rate of the treated fins was due to a proximalization
either of the regenerating tissue or the growth program of the
regenerate.
Each bony ray of the zebrafish fin bifurcates at specific
positions along the proximodistal axis (Marı´-Beffa et al., 1999).
If calcineurin inhibition proximalizes regenerating fins, this
should result in more distal bone bifurcation. To assess this,
we measured the length of bony rays from the base of the fin
to the first bifurcation point before amputation and 21 dpa in
fins treated either with DMSO or with FK506. Measurements
from the DMSO controls before and after amputation showed
very little difference (Figures 6G, 6H, and 6K), whereas FK506-
treated fins showed a clear distal shift (Figures 6I–6K) of approx-
imately 1.0mmcompared to theDMSOcontrol (Figure 6L). Thus,
calcineurin inhibition caused a significantly increased proximal
contribution to the entire ray after FK506 treatment (Figure 6L).
Consistent with their higher rate of growth, proximal blas-
temas display larger expression domains of genes required for
growth (Lee et al., 2005). We therefore assessed whether calci-
neurin inhibition leads to expansion of the expression domains
of two genes involved in ray regeneration: shh and bmp8a. As
expected, shh was expressed as larger domains in the proximal
regenerates (Figure 6N) compared to the distal regenerates
(Figure 6M) in control fins. In contrast, the shh expression do-
mains in FK506-treated fins were enlarged (Figures 6O and 6P)
so that the distal domain became similar in size to the proximalpmental Cell 28, 573–587, March 10, 2014 ª2014 Elsevier Inc. 579
Figure 5. A Calcineurin-Mediated Mechanism Regulates Growth
(A) Adult caudal fin before amputation and DMSO treatment.
(B) Amputated fin at 0 days dpa.
(C) DMSO-treated fin at 38 dpa.
(legend continued on next page)
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distal lengths of shh domains supported this interpretation
(Figure 6Q); bmp8a showed similar results (Figure 6R). Thus,
the change in growth rate, the distal shift in bifurcated sites,
and the expansion of the expression domains all support the
conclusion that calcineurin inhibition proximalizes either the
regenerating fin or the regeneration program that is executed
according to this positional information.
Calcineurin Inhibition Promotes Retinoic Acid Signaling
Retinoic-acid-mediated signaling is long known to regulate
positional growth in developing and regenerating appendages
by proximalizing the outgrowth (Maden, 1982). We therefore
compared the expression of components of the retinoic acid
(RA) signaling pathway in controls and treated regenerating
fins 28 dpa. Both FK506 (Figure 7A) and CsA (Figure 7B) induced
the transcriptional upregulation of the RA synthesizing enzyme
raldh2 and of crabp2b, a protein that binds RA and increases
RA availability to nuclear receptors (Budhu and Noy, 2002). In
addition, the expression of RA degrading enzymes such as
cyp26a1 and cyp26c1, as well as the expression of crabp2a,
which promotes transfer RA to the Cyp26 enzymes (Cai et al.,
2012), were downregulated (Figures 7A and 7B). In situ hybridi-
zation experiments confirmed the upregulation of raldh2 and
the downregulation of cyp26a1 in FK506-treated fins compared
to controls (Figures 7C–7F). Furthermore, compared to controls
(Figure 7G), FK506 treatment (Figure 7H) upregulated the
crabp2b expression along the proximodistal axis. We observed
these same results in fins treated with CsA (Figures S6A–S6D).
Thus, calcineurin inhibition promotes expression of retinoic
acid signaling components in the regenerating fin.
Retinoic acid signaling has been described to be mediated
through the Prod1 receptor and its ligand nAg (anterior gradient)
(da Silva et al., 2002; Echeverri and Tanaka, 2005; Kumar et al.,
2007a). Because we have not been able to identify the bona fide
zebrafish prod1 homolog, we examined whether the zebrafish
anterior-gradient ligand (agr2) was upregulated by FK506 and
CsA. qRT-PCR showed increased levels of agr2 in the regener-
ating fins at 28 dpa (Figure 7I). Already at 3 dpa, we observed
a punctate expression pattern primarily in the stump and prox-
imal regenerating tissue (Figures 7J and 7L) that is characteristic
of the agr2-expressing glands (Figures S6E and S6F) (Kumar
et al., 2007b), and, compared to DMSO-treated controls (Figures
S6F and S6H), the number of glands in the epidermis also(D) Adult fin before amputation and FK506 treatment.
(E) Amputated fin at 0 dpa.
(F) FK506-treated fin at 38 dpa.
(G) Adult fin before amputation and cyclosporin A (CsA) treatment.
(H) Amputated fin at 0 dpa.
(I) CsA-treated fin at 38 dpa.
(J) Graph of the fin-to-body ratios for DMSO-, FK506-, and CsA-treated fish.
(K) Percentage of calcineurin activity normalized to DMSO in DMSO-, FK506-, a
(L) ISH of calcineurin catalytic subunit in 5 dpa regenerating fins.
(L0) Magnification of regenerating rays in (L).
(M) Cross-section of adult caudal fin shows strong expression of calcineurin in t
(N) Fold change in calcineurin activity normalized to unamputated fins at differen
p values given only for significance values of 0.05 or less.
In (C), (F), and (I), black arrowheads mark the amputation planes. Black lines show
entire caudal fin. Scale bars, 1 mm (A–I), 200 mm (L and L0), and 20 mm (M). Data a
animals. See also Figure S4.
Develoincreases significantly in unamputated (Figures S6G and S6H)
and amputated fins treated with FK506 (Figure S6H). Consistent
with retinoic acid regulation of this signaling pathway, we
observed that the punctate expression of this gene distally
expanded in FK506-treated fins (Figure 7M, red lines) and
appeared denser (Figures 7K and 7M).
Early induction of raldh2 following 5 days of FK506 treatment
of unamputated fins before the onset of measurable outgrowth
(Figure 2M) suggests that the proximal allometric growth is
associated with the induction of retinoic acid signaling. Consis-
tent with this hypothesis, we observed that the transcriptional
regulation of retinoic acid signaling components in unamputated
fin was similar to amputated fins both by qRT-PCR experiments
(Figure 7N) and by in situ hybridization of raldh2 (Figures 7O and
7P), rarg (Figures 7Q, 7R, and S5G), as well as upregulation of
agr2 quantitatively (Figure 7T) and throughout the fin (Figures
7U–7X). Together, these results provide a potential mechanism
through which loss of calcineurin activity could promote rapid,
allometric proximal growth.
DISCUSSION
Experiments in several animal species demonstrate the exis-
tence of body-wide and structure-specific mechanisms that
control proportional growth. Evidence for overarching control
on proportional growth comes from experiments in which fetal
organs are transplanted into adult bodies. Whether heart,
kidney, or thymus, these structures grew to match the adult
proportions (Dittmer et al., 1974; Metcalf, 1963; Silber and Silver,
1976). Further evidence comes from doubling the nuclear ploidy
number in salamander embryos to produce animals with larger
cells. Despite having larger cells, the tetraploid animals grow to
the same size as their diploid counterparts by reducing the
number of cells (Fankhauser, 1945; Fischberg, 1958). Similar re-
sults have been obtained in mouse embryos (Henery et al.,
1992). Interestingly, part of this size control is linked to positional
information. Tissue regeneration after injury to Drosophila imag-
inal discs, mammalian fetal limbs and adult livers (Haynie and
Bryant, 1977), as well as fish and amphibian structures shows
the specific reconstruction of only the lost distal tissue to its orig-
inal size irrespective of the number of serial amputations (Aze-
vedo et al., 2012). The size information appears to be retained
locally in each adult structure, as limb bud transplantation exper-
iments in salamander or in chick embryos show that the final sizend CsA-treated regenerating fins at 7 dpa.
he blastema and weak expression in the epidermis.
t time points during regenerative outgrowth of the caudal fin of wild-type fish.
the extent of regenerative outgrowth, and red lines highlight the length of the
re represented as mean ± SD from three or more experiments with six or more
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animal host (Twitty and Schwind, 1931; Wolpert, 1981). This
intrinsic control is retained in regenerating adult structures:
transplantation of limbs and eyes between larger and smaller
Ambystoma salamanders and their subsequent amputation
results in the regeneration of these structures to the original
proportions of the donor and not of the recipient (Twitty and
Schwind, 1931).
To date, the only molecular signal known to override propor-
tional regulatory control while still producing coordinated growth
is retinoic acid (RA): RA treatment of embryonic or regenerating
adult limbs changes positional patterning information and
instructs cells to acquire proximal identities. This duplicates
existing proximal structures and lengthens overall regenerative
growth. RA signaling is thus involved in controlling both
patterning and proportional growth (Maden, 1982; Thoms and
Stocum, 1984). Based on our results, we propose that calci-
neurin is part of the regulatory mechanism upstream of the
endogenous RA signaling in the zebrafish appendages.
Immunosuppression and Growth Control
Previous findings that immunosuppressants can override the
suppression of regeneration during the regeneration refractory
period of the Xenopus larva or that certain glucocorticoid immu-
nosuppressants block zebrafish fin regeneration argue that the
immune system is involved in regulating regenerative growth
(Fukazawa et al., 2009; Mathew et al., 2007). Immune cells do
regulate the proliferation of cells in other tissues: they regulate
tumor growth through surveillance and elimination of tumori-
genic cells (Dunn et al., 2004). However, our data show that
the coordinated, allometric fin overgrowth caused by FK506
and CsA is not due to general immunosuppression; instead,
the phenotypes are specifically due to calcineurin inhibition.
Calcineurin as Molecular Switch between Isometric and
Allometric Growth
Coordinated growth involves complex interactions between
cells, and these interactions can be governed by systemic
factors (e.g., growth hormones) and by local inputs (e.g., extra-Figure 6. Calcineurin Inhibitors Promote Proximal Growth Program
(A) DMSO-treated fin 28 days after ventral proximal and dorsal distal cuts (red lin
(B) FK506-treated fin 28 days after ventral proximal and dorsal distal cuts (red lin
(C) Early growth rates of DMSO-treated regenerating caudal fin lobes after proxi
(D) Early growth rates of FK506-treated regenerating caudal fin lobes after proxi
(E) Regeneration profiles of DMSO-treated fins amputated proximally or distally.
(F) Regeneration profiles of FK506-treated fins amputated proximally or distally.
(G) Adult caudal fin before amputation.
(H) DMSO-treated fin 28 dpa.
(I) Caudal fin before amputation.
(J) FK506-treated fin at 28 dpa. In (G)–(J), red lines show length to ray bifurcation
(K) Quantification of the measurements of rays from the base to the bifurcation p
(L) Graph shows the difference in the shift in bifurcation between DMSO- and FK
(M) Whole-mount ISH for shh in distal cut DMSO-treated regenerating fin at 14 d
(N) ISH for shh in proximally amputated fin at 12 dpa.
(O) shh expression domain in distally cut regenerating FK506-treated fins at 12 d
(P) shh domain of during regeneration of FK506-treated proximally cut fin at 12 d
(Q) Length of shh expression domains in proximal and distal amputated DMSO-
(R) Length of bmp8a expression domains in proximal and distal amputated DMS
Scale bars, 2 mm (A and B) and 200 mm (G–J and M–P). Data are represented as m
and R). p values are results from unpaired t test (K, L, Q, and R).
Develocellular matrix-bound growth factors) (Stanger, 2008). Although
it is uncertain whether calcineurin is downstream of a systemic
or local regulatory stimulus that regulates fin growth, the speci-
ficity of the growth phenotype to the fin despite systemic delivery
of the calcineurin inhibitors suggests that calcineurin is regu-
lating a mechanism in the fin.
In mammals, FK506 can promote regenerative outgrowth of
specific cell types in several different organ systems. The
mammalian liver has significant capacity to regenerate (Fausto
et al., 2006), and it has been reported that FK506 or CsA treat-
ment increases the proliferative capacity of liver cells during
regeneration (Tanaka et al., 1993). FK506 has also been shown
to enhance cell proliferation of vascular smooth muscle cells
(Giordano et al., 2008) and has been described to improve nerve
regenerative repair and enhance outgrowth (Gold, 1997) (see
review in Kuffler, 2009). Our ability to promote allometric growth
by calcineurin inhibition both during steady-state isometric adult
growth and during regeneration will allow us to examine the cell
and molecular biology responsible for coordinated regenerative
outgrowth. Importantly, the link between allometric growth and
calcineurin inhibition is not restricted to the pharmacological
interventions, because endogenous calcineurin activity is
reduced following amputation, only to reappear as the fin
switches back to the isometric growth mode.
Fin growth is also disproportionately higher than growth of
the body during early stages of juvenile development. This allo-
metric growth then converts to isometric growth as the juvenile
fish becomes an adult (Goldsmith et al., 2006). Interestingly,
there are several zebrafish mutants that retain allometric fin
growth: the dominant mutants long fin (lof), rapunzel (rap), and
another long fin (alf) produce excessively long fins (van Eeden
et al., 1996; Iovine and Johnson, 2000; Johnson and Bennett,
1999; Tresnake, 1981). The clear manifestation and extent of
the allometric growth phenotype produced by our drug treat-
ments suggest that calcineurin phosphatase activity acts as a
molecular switch between isomeric and allometric growth. The
genes affected in these mutants are therefore excellent candi-
dates for factors acting either upstream of downstream of this
switch.es indicate growth).
es indicate growth).
mal or distal amputation.
mal or distal amputation.
(dashed black line).
oints in (G)–(J).
506-treated caudal fins at 28 dpa.
pa.
pa.
pa.
and FK506-treated fins at 12 dpa.
O- and FK506-treated fins at 12 dpa.
ean ± SD from three experiments containing six or more animals (C–F, K, L, Q,
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Zebrafish Fin
The growth and regulation of all tissues requires positional
information that ensures correct patterning. At specific distances
from the base of the fin, the rays branch, demonstrating that
they have clear differences in proximal and distal structure.
The consistent distal shift after FK506 or CsA treatment shows
that these calcineurin inhibitors maintain the regeneration
program that extends the proximal fin architecture. Also, treat-
ment does not produce more bifurcation points in the overgrown
fins at the same positions as control fins, which argues that the
bifurcation program is not limited to temporal oscillatory and tor-
que (bone strain) sensing mechanisms. Instead, the proximal
growth rate, the positional shift in the position of ray bifurcations,
and proximal-like size of shh as well as bmp8a, a marker of
scleroblasts in the blastema, argue that the observed switch to
allometric growth is a switch to a proximal growth program.
This conclusion fits with the observation that the RA produc-
tion program—upregulated raldh2 and rarg, downregulated
cyp26 genes—is augmented by calcineurin inhibition. In the
developing and regenerating tetrapodian limb, retinoic-acid-
mediated signal transduction patterns vertebrate appendages
along the proximodistal axis (Maden, 1982; Thaller and Eichele,
1987). Increases in RA result in the duplication of proximal struc-
tures and consequently extended outgrowth of the entire
appendage (Maden, 1982; Niazi and Saxena, 1978; Thoms and
Stocum, 1984). Previous observations from exogenous retinoic
acid treatment of regenerating fish fins showed ray fusions, ray
distortions, or increased BrdU incorporation (Blum and Bege-
mann, 2012; Ge´raudie et al., 1995; White et al., 1994), demon-
strating the ability of RA to control pattern and increase cell
proliferation. Furthermore, knockdown of raldh2 or overexpres-
sion of an enzyme that catabolizes RA prevents regeneration
by reducing cell proliferation and causing blastema degeneration
(Blum and Begemann, 2012; Mathew et al., 2009), demon-
strating the importance for RA to maintain blastema growth.
The increase in the expression of RA signaling components,
the expansion of proximal architecture, and the retention of
proximal growth rates suggest that calcineurin-mediated pheno-
type involves retinoic acid signaling to sustain the proximallyFigure 7. Calcineurin Inhibitors Regulate the Endogenous Retinoic Ac
(A) qRT-PCR comparing genes regulating retinoic acid in 28 dpa regenerating FK
(B) qRT-PCR of the same genes comparing values of regenerating CsA-treated
(C–H) ISH at 5 dpa for raldh2 of DMSO (C) and FK506-treated fins (D); for cyp26a1
treated fins (H).
(I) qRT-PCR for agr2 comparing values of FK506-treated fins to DMSO-treated fi
(J and K) agr2 ISH in 3 dpa DMSO (J) and FK506 (K) fins. Red lines in (J0) and (K
(L and M) Cross-sections of in situs for agr2 on regenerating fins after DMSO- (L
(N) qRT-PCR for retinoic acid regulating genes comparing values of FK506-treat
(O and P) raldh2 ISH for unamputated 5 dpt DMSO (O) and FK506-treated fins (P
(Q and R) rarg expression in unamputated fins 5 dpt with DMSO (Q) or with FK5
(S) qRT-PCR for rarg expression comparing values from 5 dpt FK506-treated un
(T) qRT-PCR for agr2 expression comparing values from 5 dpt FK506-treated un
(U and V) agr2 ISH of unamputated fins at 5 dpt for DMSO (U) and FK506 (V).
(U0 and V0) Enlarged fin images of indicated unpigmented find in (U) and (V), resp
pigment cell at the border of the enlarged panel (V).
(W and X) Cross-sections of in situs for agr2 on unamputated fins after DMSO- (
In (A), (B), (I), (N), (S), and (T), each point represents qRT-PCR experiments of a c
panel represents in situ results of two or more fins from three or more experiments
(O and P). See also Figure S6.
Develoassociated allometric outgrowth of the blastema. Howmuch ret-
inoic acid signaling or other signaling pathways are involved in
the calcineurin-mediated coordinated outgrowth phenotype re-
mains to be determined.
Conclusion
From this work, we uncovered a role for calcineurin in regulating
growth. We show that calcineurin inhibitors maintain allometric
growth of regenerating and developing fins by acting on a
regulatory switch between isometric and allometric growth
control. In addition, this switch regulates the endogenous
retinoic acid signaling program, a signal transduction program
known to proximalize developing and regenerating tetrapod
limbs, suggesting that RA signaling is involved in the proximal-
ized growth rate. Thus, we have uncovered a regulatory
mechanism involved in regulating proportional, coordinated
appendage growth that links endogenous retinoic acid signaling
in appendage development and regeneration.
EXPERIMENTAL PROCEDURES
Fish Husbandry
WIKstockswereused.Zebrafishweremaintainedat27Cwitha14L:10Dphoto-
period. All experiments were performed according institutional, state, and
federal guidelines under animal protocols approved by the animal welfare com-
mittees of the TechnischeUniversita¨t Dresden and the LandesdirektionSachen.
Drug Treatments
During drug treatments, fish were kept in autoclaved fish water and fed every
second day with Artemia, followed by change of the water with fresh drug.
FK506 (Sigma), cyclosporin A (CsA, Sigma), rapamycin (Calbiochem), Celas-
trol (Calbiochem), and SLF (Dr. Yixin Zhang, B-Cube, TU Dresden) were all
dissolved in DMSO (Sigma). For all experiments (except those in Figure 4L),
drugs were added to the water at following concentrations: FK506,
0.1 mg/ml; CsA, 0.5 mM; rapamycin, 50 nM; Celastrol, 50 ng/ml; and SLF,
64 ng/ml unless otherwise mentioned.
For intraperitoneal injections in Figure 4L, we used a 10 ml volume at the
following concentrations: FK506, 0.2 mg/ml working solution diluted of
10 mg/ml stock in EtOH with 2.22% Tween 20 in PBS; CsA, 1.25 mg/ml
working solution diluted of 10 mg/ml stock in EtOH with 2.22% Tween 20
in PBS; rapamycin, 0.25 mg/ml working solution diluted of 1 mg/ml stock
with PBS; and Celastrol: 0.5 mg/ml working solution diluted of 5 mg/ml stock
with PBS.id Program
506-treated fins to values of DMSO-treated regenerating fins.
fins to values of regenerating DMSO control fins at 28 dpa.
of DMSO (E) and FK506-treated fins (F); for crapb2b in DMSO (G) and FK506-
ns at 28 dpa.
0) show proximodistal range of agr2 staining.
) and FK506- (M) treated fins.
ed unamputated fins to DMSO-treated unamputated fins at 5 dpt.
).
06 (R).
amputated fins to values of DMSO-treated fins.
amputated fins to values of DMSO-treated fins.
ectively. Blue arrows indicate agr2 in situ staining. Black arrowhead indicates
W) and FK506- (X) treated fins.
DNA pool of eight harvested fins. In (C)–(H), (J)–(M), (O)–(R), and (U)–(X), each
. Scale bars, 200 mm (C–H, J, K, and Q–V), 25 mm (L, M, W, and X), and 100 mm
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Juvenile fish were stagematched based on the number of segments in the rays
of the caudal fin (Goldsmith et al., 2006). Body length was measured from the
tip of the mouth to the caudal peduncle (Iovine and Johnson, 2000), and fin
length from the caudal peduncle to the most distal tip of the fin along the
longest ray. Change in fin length in unamputated fins was analyzed by locating
the same segment before and after treatment using the bifurcation fork as a
landmark and measuring the distance to the tip of the ray.
qRT-PCR Analysis of Gene Expression
Gene expression was analyzed from pools of fin RNA, each sample consisting
of at least eight individuals. Only the tips of fins (one to three segments) were
homogenized in TriFast (PeqLab, Germany). For reverse transcription to
cDNA, including DNase digest of possible genomic DNA, the RevertAid H
Minus First Strand cDNA Synthesis Kit from Fermentas was used. qRT-PCR
was performed using the Brilliant II SYBR Green kit (Agilent) with Mx3005
machines (Stratagene). The primer sequences are listed in the Supplemental
Experimental Procedures. Cycling conditions were 10 min 95C; 40 cycles
of 30 s 95C, 1 min at gene-specific annealing temperature, 1 min 72C;
followed by melting curve analysis: 1 min at 95C, 30 s at 55C, 30 s at
95C. Gene expression levels were normalized to eef1a1l1/ef1a
(NM_131263.1) (McCurley and Callard, 2008), and fold change was calculated
using the DDCt method.
Whole-Mount In Situ Hybridization
Gene-specific sequences were cloned to the pCRII vector from 3 dpa cDNA
using primers sequences (Supplemental Experimental Procedures). DIG
probes were generated using in vitro transcription reagents from Fermentas.
In situ hybridization experiments were done using standard published proto-
cols (Kizil et al., 2009). The primer sequences for generating the probes by
PCR are listed in the Supplemental Experimental Procedures. Whole-mount
in situ hybridized fins were cross-sectioned (14 mm) on a Kryostat HM 560
(Leica) after cryoembedding the fins in O.C.T. Tissue Tek (Weckert-Labortech-
nik). Sectioned fins were imaged.
Preparation of Total Protein Lysates
Total protein lysates were prepared by homogenizing fin tissue (two distal-
most segments) in lysis buffer (Yu et al., 2006) supplementedwith 1%protease
inhibitor cocktail (P8340, Sigma) using a glass mortar. Homogenized lysates
were incubated on ice for 10 min and then spun down for 10 min with
21.1 3 g at 4C. Protein concentrations were measured using the DC Protein
Assay (Bio-Rad).
Calcineurin Activity Measurements
Calcineurin phosphatase activity in fin lysates was measured according to
Taigen et al. with small modifications (Taigen et al., 2000). The calcineurin
substrate phosphorylated RII peptide was synthesized using solid-phase
peptide chemistry. After removal of free phosphate from the sample, phos-
phorylated RII peptide was added, and the sample was incubated for 30 min
at 30C. After incubation, phosphate indicator malachite green was added,
and the amount of free phosphate in the sample was measured on a plate
reader (Beckman Coulter PARADIGM). Calcineurin activity was normalized
to total protein concentration.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at http://dx.doi.org/
10.1016/j.devcel.2014.01.019.
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